214 related articles for article (PubMed ID: 7144729)
1. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
Seiler MP; Markstein R
Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
[No Abstract] [Full Text] [Related]
2. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
Cass WA; Zahniser NR
Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
[No Abstract] [Full Text] [Related]
4. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
Martin GE; Williams M; Haubrich DR
J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
[No Abstract] [Full Text] [Related]
5. Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.
Cardellini M; Claudi F; Perlini V; Balduini W; Cattabeni F; Cimino M
Farmaco Sci; 1987 Apr; 42(4):307-17. PubMed ID: 3595841
[TBL] [Abstract][Full Text] [Related]
6. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
Friedhoff AJ; Bonnet K; Tosengarten H
Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
[TBL] [Abstract][Full Text] [Related]
7. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
8. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
9. Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.
Beart PM; Cook CJ; Cincotta M; de Vries DJ; Tepper P; Dijkstra D; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):487-93. PubMed ID: 2963964
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
[TBL] [Abstract][Full Text] [Related]
12. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
Creese I; Sibley DR; Leff SE
Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
[TBL] [Abstract][Full Text] [Related]
13. Lateralization of neocortical dopamine receptors and dopamine level in normal Wistar rats.
Nowak G
Pol J Pharmacol Pharm; 1989; 41(2):133-7. PubMed ID: 2687822
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides.
Bhargava HN
NIDA Res Monogr; 1984 Mar; 49():320-6. PubMed ID: 6148693
[No Abstract] [Full Text] [Related]
16. Dopamine receptor binding regulated by guanine nucleotides.
Creese I; Usdin TB; Snyder SH
Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
[No Abstract] [Full Text] [Related]
17. Striatal dopamine receptors and adenylyl cyclase activity in a rat model of alcohol addiction: effects of ethanol and lisuride treatment.
May T; Wolf U; Wolffgramm J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1195-203. PubMed ID: 8531081
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
Valchár M; Dobrovský K; Krejcí I; Dlabac A
Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
[No Abstract] [Full Text] [Related]
20. The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases.
Sheppard H; Burghardt CR; Long JP
Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):213-24. PubMed ID: 205926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
